AxioMed LLC
$5.8M 1 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Linvatec Corporation
Linvatec Corporation reported $5,796,661.40 across General Payments, Research, and Ownership to 2,929 physicians and teaching hospitals across 2,986 transactions.
- $5.8M
- All-tracks total
- 2,986
- Transactions
- 2,929
- Recipients
- +$662.3K
- General Payments vs PY2023
Linvatec Corporation reported $5,796,661.40 across all CMS Open Payments tracks (General + Research + Ownership) to 2,929 physicians and teaching hospitals in Program Year 2024 - ranking #253 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $5,301,184.76, averaging $2.0K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer linvatec-corporation Linvatec Corporation
$5.8M · #253/1,925 · 0.0% industry · PY2024
- TOT $5.8M
- RANK #253
- SHARE 0.0%
- TXN 2,986
- RCP 2,929
- CAT 12
- GEN $5.3M
- ΔGEN +$662.3K
- TOP1 18.7%
- PY 2024
Volume peers
Nearest volume peer: AxioMed LLC ($5.8M)
Linvatec Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Linvatec Corporation's CMS-reported General Payments increased by $662.3K (+14.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LINVATEC CORPORATIONPY2023: LINVATEC CORPORATIONPY2024: Linvatec Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,638,926.89
- PY2024
- $5,301,184.76
What the Data Shows for Linvatec Corporation
Averaging $1.9K per transaction and $2.0K per recipient, Linvatec Corporation's Program Year 2024 total comes to $5,796,661.40 across 2,986 transactions and 2,929 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #253 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 12-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Acquisitions" at $1.9M, accounting for 35.6% of this company's General Payments and 156 transactions.
General Payment Breakdown by Type
Across 12 types of general payments, Linvatec Corporation's largest category was "Acquisitions" at $1.9M - 35.6% of General Payments.
Linvatec Corporation reports 12 general-payment categories - the top three are Acquisitions (35.6%), Royalty or License (26.2%), and Consulting Fee (13.3%). The remaining 9 categories make up 24.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Linvatec Corporation files across 12 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Linvatec Corporation divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Acquisitions | $1.9M | 156 | 35.6% |
| Royalty or License | $1.4M | 242 | 26.2% |
| Consulting Fee | $702.9K | 276 | 13.3% |
| Long-Term Medical Supply or Device Loan | $622.4K | 280 | 11.7% |
| Travel and Lodging | $301.6K | 353 | 5.7% |
| Grant | $190.0K | 10 | 3.6% |
| Food and Beverage | $128.0K | 1,586 | 2.4% |
| Space Rental or Facility Fees | $57.8K | 15 | 1.1% |
| Compensation for Faculty or Speaker (Medical Education) | $13.8K | 6 | 0.3% |
| Charitable Contribution | $5.0K | 1 | 0.1% |
| Education | $2.5K | 1 | 0.0% |
| Entertainment | $78.34 | 3 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,738,680.08 (32.8%) of $5,301,184.76 in this company's General Payments records across 1,520 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Linvatec Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Nirav Amin
$989,515.70 across 11 reported transactions
- 2
Jeffrey Abrams
$225,590.21 across 11 reported transactions
- 3
Felix Savoie
$218,568.55 across 4 reported transactions
- 4
Robert Meislin
$175,182.28 across 7 reported transactions
- 5
Richard Bernstein
$129,823.34 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Linvatec Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Linvatec Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Linvatec Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
OMNIlife science, Inc
$5.8M 829 recipients
Compare payment profiles
Highridge Medical LLC
$5.8M 2,278 recipients
Compare payment profiles
Ipsen Innovation
$5.8M 124 recipients
Compare payment profiles
Intercept Pharma Europe Ltd.
$5.9M 0 recipients
Compare payment profiles
Nalu Medical, Inc.
$5.7M 9,707 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.